Clin Ultrasound.
2022 Nov;7(2):90-94. 10.18525/cu.2022.7.2.90.
Management of Ipsilateral Axillary Lymphadenopathy Detected on Breast Ultrasound after COVID-19 Vaccination
- Affiliations
-
- 1Department of Breast Surgery, Kosin University Gospel Hospital, Kosin University College of Medicine, Busan, Korea
- 2Department of Endocrine Surgery, Kosin University Gospel Hospital, Kosin University College of Medicine, Busan, Korea
- KMID: 2555154
- DOI: http://doi.org/10.18525/cu.2022.7.2.90
Abstract
- The coronavirus disease 2019 (COVID-19) pandemic has significantly impacted morbidity and mortality worldwide. The rollout of vaccination programs remains the most helpful action to contain coronavirus dissemination. COVID-19 vaccines are commonly administered intramuscularly into the arm. Ipsilateral axillary lymphadenopathy has been reported as an adverse event after COVID-19 vaccination. Axillary lymphadenopathy following COVID-19 vaccination may mimic metastasis. A major concern is that this finding could lead to a misdiagnosis in patients with various types of malignancy, especially breast cancer. This article reviewed the management and reports of ipsilateral axillary lymphadenopathy caused by the COVID-19 vaccine with a focus on ultrasound.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Ipsilateral Lymphadenopathy After COVID-19 Vaccination in Patients With Newly Diagnosed Breast Cancer
- Precautions for breast ultrasound examination following COVID-19 vaccination
- Ipsilateral Malignant Axillary Lymphadenopathy and Contralateral Reactive Lymph Nodes in a COVID-19 Vaccine Recipient With Breast Cancer
- COVID-19 Vaccine-Related Axillary and Cervical Lymphadenopathy in Patients with Current or Prior Breast Cancer and Other Malignancies: Cross-Sectional Imaging Findings on MRI, CT, and PET-CT
- Ipsilateral Radial Neuropathy after COVID-19 mRNA Vaccination in an Immunocompetent Young Man
